Clopidogrel and Apixaban: Interaction Details

Brand names
Clopidogrel
Plavix
Apixaban
EliquisELIQUIS 30-Day Starter PackEliquis Sprinkle
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Apixaban

Brand names
  • Eliquis
  • ELIQUIS 30-Day Starter Pack
  • Eliquis Sprinkle

What Happens When You Take Clopidogrel With Apixaban

What can happen when they are taken together (rated Major)

Increased risk of bleeding and can cause serious, potentially fatal bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Bleeding risk rises when apixaban is given together with agents.2 In any patient receiving alongside antiplatelet drugs, signs or symptoms of blood loss warrant prompt evaluation.3

Patients should be informed about the signs and symptoms of blood loss and instructed to report them right away or seek care at an emergency room. Apixaban should be stopped in patients who have active pathological , and this instruction applies again in the context of managing bleeding: apixaban is to be discontinued when active pathological hemorrhage is present.

The effect of apixaban is expected to last for no less than 24 hours following the final dose. A reversal agent for the anti-factor Xa activity of apixaban is available.

Consideration may also be given to prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa. If PCCs are administered, monitoring the anticoagulant effect of apixaban with a clotting test (PT, , or aPTT) or with anti-factor Xa (FXa) activity is neither useful nor recommended. Activated oral charcoal decreases apixaban and, as a result, lowers its .2

The Clopidogrel and Apixaban Interaction, Explained

Clopidogrel (Plavix) keeps from sticking together, and apixaban (Eliquis) slows the clotting process in your blood. Each one lowers your body's ability to form clots in a different way, so taking them together can raise your chance of bleeding. Sometimes that bleeding can be serious.

Many people take both for good reasons, such as after a heart stent. Watch for unusual bruising, nosebleeds or gum bleeding that won't stop, blood in your urine, black or bloody stools, or vomiting blood. Report these right away, or go to the emergency room if bleeding is heavy. Keep taking both as prescribed. Your care team can manage this and may monitor you more closely.

Mechanism: , impairment of hemostasis (P2Y12 by clopidogrel plus direct factor Xa inhibition by apixaban). No relevant PK interaction is expected, so apixaban exposure (/) is not altered.

Effect: Increased bleeding risk, including serious or fatal . Onset unspecified; evidence rated theoretical on file, though the additive mechanism is pharmacologically plausible. Severity: major.

  • Confirm the combination is clinically indicated and counsel on bleeding signs.
  • Promptly evaluate any signs of blood loss; discontinue apixaban for active pathological hemorrhage.
  • Apixaban PD effect persists at least 24 h after the last dose. A specific anti-FXa reversal agent is available; PCC, aPCC, or rFVIIa may be considered. PT, , aPTT, and anti-FXa are not useful for monitoring after PCC.
  • Activated charcoal reduces apixaban .

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Clopidogrel and Apixaban Interact

The likely mechanism

effects on hemostasis

In short: Clopidogrel and apixaban both make bleeding more likely, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Clopidogrel and Apixaban Interaction

When clopidogrel and apixaban are used together, your care team weighs the benefits against the bleeding risk and may monitor you more closely. If serious bleeding happens, they have treatments available, including a medicine that can reverse apixaban's effect.

  • Keep taking both medicines exactly as prescribed. Do not stop either one on your own.
  • Learn the signs of bleeding: unusual bruising, bleeding gums, nosebleeds, red or dark urine, black or bloody stools, or coughing or vomiting blood.
  • Report bleeding right away, or go to the emergency room if it is heavy or won't stop.
  • Ask your pharmacist before taking other products that can add to bleeding risk.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Clopidogrel or Apixaban need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ELIQUIS oral film coated tablets, apixaban oral film coated tablets

    APPRAISE-2, a clinical trial enrolling high-risk patients after acute coronary syndrome who were treated with aspirin or with aspirin plus clopidogrel, was stopped early because bleeding occurred at a higher rate with apixaban than with placebo. Among patients on single therapy, ISTH major bleeding occurred at 2.8% per year with apixaban compared with 0.6% per year with placebo, and among those on dual antiplatelet therapy, the rates were 5.9% per year with apixaban compared with 2.5% per year with placebo.2

  2. Report 2 · Study title

    Prescribing information: ELIQUIS oral film coated tablets, apixaban oral film coated tablets

    In the ARISTOTLE clinical trial, among patients taking apixaban, adding aspirin raised the bleeding risk from 1.8% per year to 3.4% per year, and adding aspirin and warfarin raised the bleeding risk from 2.7% per year to 4.6% per year. Dual therapy was used with apixaban to a limited extent (2.3%) in this trial.2

  3. Report 3 · Study title

    Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes

    In a retrospective study, combined direct oral (DOAC) and therapy (APT; n=78), compared with DOAC therapy alone (n=329), did not significantly change the incidence of major bleeding (1.3% vs 1.2%) or clinically relevant non-major bleeding (10.2% vs 6.4%) during 6 months of treatment. The study population consisted mainly of Caucasian men, with a mean age of 63.7 years.

    Compared with patients prescribed DOAC monotherapy, those receiving concurrent APT had a significantly higher mean body mass index (30.7 vs 28.4) and mean CHA2DS2-VASc score (4.28 vs 3.85), and were more likely to have diabetes (26.9% vs 17.3%). DOACs were prescribed for atrial fibrillation or VTE treatment and consisted of apixaban (58.5%), rivaroxaban (38.1%), and dabigatran (3.4%).

    Single antiplatelet therapy was used in 94.9% (74 patients), and the most common regimen was aspirin 81 mg once daily (69 patients). The remaining APT regimens were aspirin 81 mg twice daily (3 patients), aspirin 325 mg daily (1 patient), clopidogrel 75 mg daily (1 patient), and dual APT consisting of aspirin 81 mg and clopidogrel 75 mg daily (4 patients).1

Clopidogrel and Apixaban: Common Questions

How serious is the Clopidogrel and Apixaban interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Clopidogrel and Apixaban interaction managed?

When clopidogrel and apixaban are used together, your care team weighs the benefits against the bleeding risk and may monitor you more closely. If serious bleeding happens, they have treatments available, including a medicine that can reverse apixaban's effect. Keep taking both medicines exactly as prescribed. Do not stop either one on your own. Learn the signs of bleeding: unusual bruising, bleed… Management is individual — always follow your own care team's guidance.

How far apart should I take Clopidogrel and Apixaban?

The interaction record says to take apixaban at least 24 hours after clopidogrel.

Your pharmacist can help you fit this into the times you take your other medicines.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Clopidogrel and Apixaban Interaction

Ask in your own words about taking Clopidogrel and Apixaban together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Tinkham TT, Vazquez SR, Jones AE, et al: Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes. J Thromb Thrombolysis 2020; 49(3):492-496. PubMed
  2. Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
  3. Product Information: SAVAYSA(R) oral tablets, edoxaban oral tablets. Daiichi Sankyo Inc (per FDA), Basking Ridge, NJ, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Clopidogrel and Apixaban

Also serious with Clopidogrel

Also serious with Apixaban

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Clopidogrel

With Apixaban

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.